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Introduction
Sepsis is a major problem in emergency departments and hospitals causing significant morbidity and mortality.
1,2 A steady increase in the incidence of sepsis has been noted worldwide, with recent UK estimates of around 50 cases of severe sepsis per 100,000 people per year. 3 Collecting data on accurate mortality figures is difficult, but recent estimates suggest an estimated case mortality of between 20-35%, although rates differ widely by definition. 4, 5 Timely diagnosis of patients with sepsis can be difficult, because of the differences in clinical presentations, and few uniquely identifying features, especially in the elderly. 6 Once patients with sepsis are identified, rapid treatment has been shown to improve mortality, although nearly all evidence comes from observational studies. [7] [8] [9] Due to the significant number of patients who present with sepsis, it is critical to identify the patients at risk of deterioration, and patients requiring urgent treatment or critical care input.
Alongside this, there is also a need to identify the significant number of patients who are likely to have a good outcome and hence can be managed more conservatively.
Early Warning Scores (EWS) are physiological composite scores comprising pulse rate, blood pressure, temperature, respiratory rate, mental state and oxygen saturation. Each of these physical observations are given a score, where 0 is considered normal. Simple addition of these observations allows a total score to be calculated, usually between 0 and 12.
Different versions of EWS often have minor modifications, such as the addition of points if
the patient is receiving oxygen therapy, or variations in specific cut-offs.
Recently, the UK National Institute for Health and Care Excellence (NICE) has published guidelines on the recognition, diagnosis and management of sepsis. 10 These guidelines recommend considering the use of Early Warning Scores in assessing patients with suspected sepsis in acute hospital settings, and highlight this area as a key research topic.
The 2015 National Confidential Enquiry on Patient Outcome and Death report on sepsis also suggested use of EWS as a principal recommendation in all care settings, specifically to assess severity of sepsis and to prioritise urgent care.
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Over the last ten years, EWS have been introduced into nearly all UK hospitals, and are already recommended in NICE guidance for monitoring critically ill patients in hospital and Royal College of Physician guidance for monitoring of all adult patients in acute hospital settings, . 12, 13 They have recently been introduced into emergency departments, and also into many ambulances services and community settings and primary care. 14 Given these scores are often calculated on every patient, there have been concerns about the volume of workload created and the sensitivity of these scores for identifying unwell patients. 15 EWS are often used, both informally and formally, to guide treatment decisions such as the best location for care (inpatient, outpatient, ICU), and the level of monitoring or seniority of doctor that should see the patient. In some centres, a certain score (for example, greater than 5), will trigger a pager alert to senior medical staff or critical care outreach services.
Although there is some evidence that this method identifies sick patients, the evidence relating to patients with sepsis is limited. 16, 17 Methods A protocol was developed based on recommended standards for conduct of systematic reviews. 18, 19 The review was registered with PROSPERO (CRD42016047125), and the PRISMA guidelines were followed when reporting results.
Study identification MEDLINE, EMBASE, CINAHL, the Cochrane Library, and Web of Science were searched from inception to October 2016. The search strategy combined terms for sepsis with terms for EWS. The full search study is available as a web appendix. References of included studies were screened and all first authors emailed to identify additional relevant studies.
Study Selection
Studies were eligible for inclusion if they assessed any form of Early Warning Score for the prediction of mortality in adult patients with sepsis. Studies were required to report sufficient data to construct a 22 were excluded. Studies were limited to secondary care facilities. A diagnosis of sepsis was considered as any diagnosis made prospectively or retrospectively by physicians, and coded as such. Mortality data was ideally 28-day mortality, but any form of mortality reporting was accepted. Mortality was chosen as this is the most commonly reported and most important outcome in sepsis.
Two reviewers (AB, DA) independently screened titles and abstracts identified by the search.
Full text articles considered potentially relevant were obtained. Inclusion assessment was performed by a third reviewer (FH); disagreements were resolved through consensus between all three.
Data extraction and quality assessment
Data on study design, number of participants, country, setting, EWS methodology, definitions of sepsis, mortality, sensitivity, specificity and area under the curve (AOC) were extracted using a predesigned form. If studies did not publish 2 x 2 data, this was calculated from the number of participants, sensitivity, specificity, and mortality. Where studies reported more than one set of 2x2 data, for example for different thresholds, then each set of 2x2 data was extracted. Study quality was assessed using the QUADAS-2 tool. 20 We modified our QUADAS assessment to look specifically at whether studies were biased by the use of EWS reducing mortality. If an EWS was in use and was acted on, this would be expected to impact on mortality and so would bias any estimate of the accuracy of NEWS in predicting mortality. This is because EWS should identify patients who are deteriorating and action should have been taken which may have reduced mortality -known as treatment paradox in the context of diagnostic test evaluation. Data extraction and quality assessment were carried out by one reviewer and checked by a second. Disagreements were resolved through discussion.
Data synthesis and analysis
We calculated sensitivity and specificity for each set of 2x2 data and plotted these in summary receiver operating characteristic (SROC) space. Where studies reported data for multiple thresholds, data for the threshold most similar to that in other studies were extracted. Only one set of 2x2 data per study contributed to the analysis. The bivariate/hierarchical summary receiver operating characteristic (HSROC) models were used to estimate summary sensitivity and specificity with 95% confidence and prediction regions around the summary points and to derive an HSROC curve. This approach allows for between-study heterogeneity in sensitivity and specificity, and for the trade-off (negative correlation) between sensitivity and specificity commonly seen in diagnostic meta-analyses.
Heterogeneity was assessed visually using the SROC plot. Summary positive and negative likelihood ratios were derived from the summary estimates of sensitivity and specificity. We also estimated the summary area under the ROC (AUC) by pooling AUCs reported in individual studies using a random effects model. We used Stata 13 (StataCorp LP, College Station, Texas, USA), mainly using the metandi . We conducted sensitivity analysis to investigate the effect of type of early warning score, study quality, setting, and threshold. Analyses were restricted to studies that were considered at low risk of bias or low/unclear concerns regarding applicability across all QUADAS-2 domains, to studies conducted in the ED, and to studies that used a threshold of ≥5 to define a positive EWS result. We also conducted subgroup analyses stratified according to type of EWS.
A flow diagram was created to put these results into clinical context. This shows the results that would be obtained if EWS were used in a hypothetical population of 1000 patients presenting to the emergency department with sepsis where 150 (15%) will die. This figure was chosen as the average mortality across our six studies was around this.
Results Figure 1 shows the flow of studies through the review process. The searches identified 620 possible studies, of which 6 were included (4,298 participants). Two of the studies were conducted in the UK 22, 23 , and one each in Germany 24 , Israel 25 , Italy 26 and Turkey 27 ( Table 1 ).
The Italian study was available as a conference abstract only.
Four studies were performed in emergency departments [22] [23] [24] 27 ; two were in internal medicine. 25, 26 Three studies were relatively small in size (<400 participants), 23, 24, 27 one was moderate (n=535) 26 and two included more than 1000 participants. 22, 25 Five studies used the MEWS system, one study used the National Early Warning Score (NEWS), a slight variation. 13,22 NEWS and MEWS both include respiration rate, oxygen saturation, supplemental oxygen, temperature, blood pressure, heart rather and level of consciousness.
The NEWS score includes scoring for oxygen saturation, whereas the MEWS score includes scoring for urine output.
Three studies used the American College of Chest Physicians / Society of Critical Care
Medicine (ACCP/SCCM) consensus definition as the basis of their sepsis diagnoses. 22, 25, 27 One study was conducted across two sites, one site used the consensus definition, the other used a 'clinician suspicion of infection' alongside evidence that blood cultures had been drawn. 23 One study only reported that patients has "objectively diagnosed sepsis." 26 The final study concentrated on 'suspected sepsis' using some of the ACCP/SCCM definition or a 'working diagnosis that included sepsis'. 24 Two studies were retrospective case note reviews 22, 23 , three identified sepsis prospectively. [25] [26] [27] One study 24 used prospective identification, but allowed retrospective case note review to ensure no missed cases.
Two studies were judged at low risk of bias for all QUADAS domains ( Table 2) . The Italian study, 26 which was available only as an abstract, was judged as unclear risk of bias for all domains except the reference standard domain for which it was judged as low risk of bias. This is because insufficient information was available to reach a judgement for the other domains. Three studies were rated at high risk for bias in terms of flow and timing. These were all prospective studies that recorded EWS in real time. This leads to the potential to them being acted upon -the 'treatment paradox', and hence lowering mortality and biasing our estimate of EWS accuracy. 24, 25, 27 There were some concerns regarding the applicability of studies to the review question. The Italian study was judged at unclear concerns regarding applicability for all domains due to the lack of information available. There were high concerns about the applicability of the population in one study 24 . Diagnostic criteria for sepsis were 'suspected sepsis' rather than confirmed sepsis and more than 20% of patients included had a final diagnosis that was not sepsis. The applicability of the index test (EWS) was considered as unclear in four studies as the time point at which the EWS was performed was not documented (i.e -whether on admission to hospital, or during the stay in the ED). 23, 24, 26, 27 Given that EWS are based on physiology, and hence change continually and with treatment, there was the potential for this to have affected the applicability of results if EWS had not been recorded on admission. One study was considered at high concern regarding applicability. 24 The definition of mortality in this study was in hospital mortality compared to our outcome of interest of 30 day mortality. The accuracy of EWS for prediction of mortality at this time point may be different and so this was flagged as a high concern regarding applicability.
Estimates of sensitivity and specificity showed considerable heterogeneity across studies.
Specificity ranged from 34 to 89%, and specificity from 30 to 84% (Table 1 ). The summary ROC plot (figure 2) shows individual study estimates of sensitivity and specificity, the summary estimate across studies and the HSROC curve. Individual estimates of sensitivity and specificity were close to the HSROC curve, suggesting that much of the variation across studies was a result of the trade-off between sensitivity and specificity. The area under the curve (AUC) was more similar across studies, ranging from 0.59 to 0.72 with a summary AUC of 0.68 (95% CI 0.65, 0.71; 5 studies). Summary sensitivity was 66% (95% CI 46, 81%), and summary specificity was 62% (95% CI 45, 76%) based on all six studies. These estimates should be interpreted with some caution due to the observed heterogeneity. There was less heterogeneity in likelihood ratios with positive likelihood ratios ranging from 1.27 to 2.06 and negative likelihood ratios ranging from 0.33 to 0.79. The summary positive likelihood ratio was 1.79 (95% CI 1.53, 2.11) and summary negative likelihood ratio was 0.59 (95% CI 0.45, 0.78). These suggest that EWS cannot be used to rule in or rule out mortality.
We investigated the effect of study quality, type of EWS, threshold and setting on results (Table 3) . We restricted analysis to studies at low risk of bias (n=2), studies with low concern regarding applicability (n=2), studies with low or unclear concerns regarding applicability (n=5), studies conducted in emergency departments (n=4), studies that evaluated the MEWS score (n=5) and studies that defined a score of 5 or more as a positive EWS result (4 studies this was the largest study included in the review and was considered at low risk of bias.
To put the above figures in context, Figure 4 shows that in theory, if EWS were to be used in a group of 1000 patients presenting to the emergency department where 150 (15%) will die, an estimated 422 will have an EWS predicting mortality but only 99 (24%) will actually die.
Of the 578 people with a result suggesting they will not die, 51 (9%) will die.
Discussion

Summary of findings
We identified six relevant studies for inclusion in our review. Results suggest that EWS cannot be used to predict who will (positive likelihood ratio 1.79, 95% CI 1.53, 2.11) or will not (negative likelihood ratio 0.59, 95% CI 0.45, 0.78) die in patients with sepsis. Sensitivity analyses suggested that results were similar when restricted to studies at low risk of bias, studies with low concern regarding applicability, studies with low or unclear concerns regarding applicability, studies conducted in emergency departments, and studies that defined a score of 5 or more as a positive EWS result. There was some evidence that MEWS may be slightly better at predicting who will die but worse at predicting who will not die than the NEWS score. However, results from sensitivity analyses should be interpreted with extreme caution due to the small number of studies included in the review.
Study quality was variable, with two studies rated as low risk of bias on all domain and, three studies rated as high risk of bias as there was it was possible that the EWS result was acted on prior and so could have affected the outcome. One study was available only as a conference abstract, and as such was judged at unclear risk of bias. There were some concerns regarding applicability because of diagnosis of sepsis in one study, lack of information on when the EWS was performed in four studies, and in-hospital mortality rather than 30-day mortality as an outcome in one study.
Strengths and weaknesses of this review
Strengths of this review include a sensitive search strategy across multiple databases. We therefore consider it unlikely that we have missed relevant studies. We included a search of conference abstracts to minimise the likelihood of publication bias and contacted authors of included studies to ask them if they were aware of any additional studies. It was not possible to formally assess publication bias as methods commonly used to detect this are not suitable for use in test accuracy reviews. 19 However, publication bias may be less of a problem for studies of diagnostic test than for reviews of interventions. A recent study found that studies reporting higher accuracy were no more likely to be reported in full. 28 Two reviewers were involved in all stages of the review process minimising the likelihood that bias or errors were introduced during the review process. We used statistically robust hierarchical models to estimate summary sensitivity and specificity and to derive summary received operating characteristic plots. These allow for both between-study variability in sensitivity and specificity, and the negative correlation between them. 21 We used the validated QUADAS-2 criteria to assess study quality. We incorporated the results of the quality assessment into our synthesis by restricting analyses to studies judged as low risk of bias or applicability.
There are many variations of EWS using different scoring systems. We included studies of any EWS in our review but only identified studies evaluating MEWS or NEWS. Our analysis restricted to studies that had evaluated MEWS showed it was slightly better at predicting mortality than NEWS, but worse at ruling mortality out. However, as only one study evaluated NEWS there were not sufficient data to allow firm conclusions regarding whether there is a difference in accuracy of these two scores. As we did not identify studies of other EWS it is not possible to determine whether these might have differing accuracies from those EWS included in our review.
Two new diagnostic criteria for sepsis have been published this year -US consensus guidelines (SEPSIS-3) and new guidance from NICE 10, 29 . The SEPSIS-3 guidelines in particular differ quite significantly from the ACCP/SCCM definition used by the studies included in our review. Given the change in diagnostic criteria, the group categorised as having sepsis may well differ significantly from previous studies. The accuracy of EWS for predicting mortality in patients diagnosed according to new criteria may therefore not be the same as those diagnosed using previous diagnostic criteria.
The treatment paradox -where the observed mortality may be significantly lower in studies where EWS are acted upon, is a high potential for bias in prospective studies introducing EWS. Three of our six studies were potentially at risk of this, although mortality in each of these studies was not substantially different from the other three studies (mean mortality 22.7% vs 17.5%).
Finally, and importantly, EWS were not designed to be used as single time point diagnostic or predictive tools. They are intended to be used to 'track and trigger' individual patients, and hence the evaluation of 'one off' EWS may not reflect day to day clinical practice.
Estimates of accuracy from these studies therefore only show how accurate a single time point assessment of EWS is in predicting mortality. Accuracy may be different if multiple time points were considered. However, we were unable to find any studies in sepsis evaluating EWS in any other context except 'one off' readings. Alongside this, the timings of the particular EWS measurement were not clear in many of the studies (i.e. if they were the first or the worst set of observations taken). Given the dynamic nature of sepsis, and heterogeneous nature of EWS usage in these studies, this is an important consideration.
Comparisons with previous literature
We are unware of any other systematic review that have evaluated EWS in patients with sepsis. Previous literature around EWS in other patient populations has been studied more extensively. A review conducted in 2014 30 found that EWS can predict cardiac arrest or death in patients on hospital wards, estimating an area under the curve of between 0.88-0.93 based on eight studies, but noted significant methodological limitations in the studies.
Another review of EWS for predicting mortality, also published in 2014, was unable to draw conclusions due to substantial heterogeneity of EWS systems alongside poor methodology 31 .
One study, by Quan et al was identified as a conference abstract but did not have enough extractable data to be included in the formal SR. This was a retrospective study of ED patients with sepsis, that showed an area under the curve of 0.61 (0.52-0.70) for predicting mortality, but we were unable to gather any further information (despite emailing the lead author) 32 .
We are aware of two further primary studies on early warning scores in specific infections rather than sepsis. One study has been published on EWS in Gram-negative bacteraemia 33 .
This study collected EWS data for multiple days prior to and after the onset of bacteraemia, and found cumulative EWS scores (over multiple days) to be highly predictive of mortality (AUC 0.90, for a 7 day average of EWS after onset of bacteraemia). Another study looked at standardised early warning scores (SEWS) in patients with pneumonia 34 . This study included 419 patients with pneumonia, and found a sensitivity of 52% and specificity of 67% for predicting mortality, similar to our study
Implications for practice
This review suggests that EWS cannot be used to predict who will or will not die in patients with sepsis, although the quality of studies was poor. This is important for two reasons.
Firstly, we should not be using EWS alone to prognosticate in patients with sepsis. They are not accurate enough to guide treatment decisions alone (on this data), such as whether or not patients should be admitted to ITU or remain on wards.
Secondly, EWS is now commonly used in the triage of patients presenting to healthcare facilities at different levels such as primary care or ED in the secondary / tertiary care hospitals. This approach is now endorsed by NICE for patients with 'suspected sepsis', based on the assumption that these scores predict mortality and other outcomes, and was a principal recommendation in the 2015 NCEPOD report on sepsis. Although this review did not look at the predictive value of EWS in the setting of 'suspected sepsis', it would seem likely that EWS will have a poor performance in this group too, given that EWS does not predict mortality in sepsis.
Therefore, EWS is not likely to be sensitive or specific enough to perform a triaging role alone, and is likely to lead to a significant increase in resources spent on low risk patients with suspected sepsis (if a low cut off is used), or missing of patients with a high mortality (if a high cut off is used).
Implications for Research
As noted above, there have been two new consensus guidelines on diagnosis of sepsis published this year 10, 29 . It will be important to re-assess tools such as EWS in patients diagnosed with sepsis based on these new criteria, as they may perform quite differently.
Secondly, there has been a gradual introduction of NEWS in the ambulance services and the community in the U.K, and research might be best to concentrate on NEWS in particular, alongside research comparing this to other EWS.
Hence, large scale, multi-centre studies are needed to further assess the role of EWS in sepsis in the community and in ambulance or similar services. Further research would also be useful in patients with suspected sepsis, and perhaps in using multiple recordings of EWS in an emergency department stay to assess response to early treatment.
Conclusions
EWS have poor prognostic value in predicting sepsis mortality. Based on the existing data, which is of poor quality, EWS should not be used on their own to guide prognosis in patients with sepsis, and are unlikely to be reliable alone in identifying patients at risk or death.
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